Citiation Clinical experimental oncology

Herrmann J, Lerman A, Sandhu NP, Villarraga HR, Mulvagh SL, et al.(2014) Evaluation and management of patients with heart disease and cancer: cardio-oncology. InMayo Clinic Proceedings 89: 1287-1306.

Barros-Gomes S, Herrmann J, Mulvagh SL, Lerman A, Lin G, et al.(2016) Rationale for setting up a cardio-oncology unit: our experience at Mayo Clinic. Cardio-Oncology. 2: 5.

Yutaka Yonemura, Akira Mizumoto, Masamitsu Hirano, Koichi Noguchi (2016) Comprehensive treatment aiming at curing against peritoneal dissemination of colorectal cancer Journal of the Japanese Colorectomy Association. 69 : 135-46.

Ralapanawe S, Walkden-Brown SW, Renz KG, Islam AF (2016) Protection provided by Rispens CVI988 vaccine against Marek's disease virus isolates of different pathotypes and early prediction of vaccine take and MD outcome. Avian Pathology. 45: 26-37.

Pereira JF, Awatade NT, Loureiro CA, Matos P, Amaral MD, et al. (2016)The third dimension: new developments in cell culture models for colorectal research. Cellular and Molecular Life Sciences. 73: 3971-3989.

Kaur J, Kaur H (2015) Advantages and effectiveness of bacterial culture in medical laboratories. International Journal. 3:1028-1039.

Pateria S, Poflee S, Gaikwad A, Bode A. Tumoral Calcinosis at Unusual Site: Diagnosis on Fine Needle Aspiration Cytology.

Zhou, Q, Fan, Y, Wu, N, Huang, Y, Wang, Y, Li, L, ... & Qiao, Y. (2014). Demonstration program of population‐based lung cancer screening in C hina: Rationale and study design. Thoracic cancer, 5(3), 197-203.

Zhou, Q, Fan, Y, Wu, N, Huang, Y, Wang, Y, Li, L, ... & Qiao, Y. (2014). Demonstration program of population‐based lung cancer screening in C hina: Rationale and study design. Thoracic cancer, 5(3), 197-203.

Zhou, Q, Fan, Y, Wu, N, Huang, Y, Wang, Y, Li, L, ... & Qiao, Y. (2014). Demonstration program of population‐based lung cancer screening in C hina: Rationale and study design. Thoracic cancer, 5(3), 197-203.

Marquez, S. B. (2014). Discovery of BRM Promoter Polymorphisms: Importance in Risk Stratification and Clinical Application. Journal of Postdoctoral Research November, 17, 26.

de Lera Ruiz, M, & Kraus, R. L. (2015). Voltage-gated sodium channels: structure, function, pharmacology, and clinical indications. Journal of medicinal chemistry, 58(18), 7093-7118.

Roger, S, Gillet, L, Le Guennec, J. Y, & Besson, P. (2015). Voltage-gated sodium channels and cancer: is excitability their primary role?. Frontiers in pharmacology, 6, 152.

Zostawa, J, Adamczyk, J, Sowa, P, & Adamczyk-Sowa, M. (2017). The influence of sodium on pathophysiology of multiple sclerosis. Neurological Sciences, 38(3), 389-398.

Yu, L, Toriseva, M, Tuomala, M, Seikkula, H, Elo, T, Tuomela, J, ... & Alanen, K. (2016). Increased expression of fibroblast growth factor 13 in prostate cancer is associated with shortened time to biochemical recurrence after radical prostatectomy. International journal of cancer, 139(1), 140-152.

Iamshanova, O, Mariot, P, Lehen’Kyi, V. Y, & Prevarskaya, N. (2016). Comparison of fluorescence probes for intracellular sodium imaging in prostate cancer cell lines. European Biophysics Journal, 45(7), 765-777.

周蕊, 卢宗亮, 刘凯, 杨柳娜, 胡叶敏, 常徽, ... & 许红霞. (2014). 人工合成钠离子通道阻断剂抑制前列腺癌细胞的生长及侵袭. Ã§Â¬Â¬Ã¤Â¸â€°Ã¥â€ â€ºÃ¥Å’»å¤§å­¦å­¦æŠ¥, 36(5), 422-426.

Yu, L. (2016). Role of fibroblast growth factors and their receptors in prostate cancer.

Yapa, K. T, Deuis, J, Peters, A. A, Kenny, P. A, Roberts-Thomson, S. J, Vetter, I, & Monteith, G. R. (2018). Assessment of the TRPM8 inhibitor AMTB in breast cancer cells and its identification as an inhibitor of voltage gated sodium channels. Life sciences, 198, 128-135.

Ceniccola, K. E. (2014). The Glucagon Receptor Functions as a Tumor Suppressor in Hepatocellular Carcinoma (Doctoral dissertation, The George Washington University).

Zhong, L, Zhang, X, & Covasa, M. (2014). Emerging roles of lactic acid bacteria in protection against colorectal cancer. World Journal of Gastroenterology: WJG, 20(24), 7878.

Ambalam, P, Raman, M, Purama, R. K, & Doble, M. (2016). Probiotics, prebiotics and colorectal cancer prevention. Best practice & research Clinical gastroenterology, 30(1), 119-131.

Saber, A, Alipour, B, Faghfoori, Z, & Yari Khosroushahi, A. (2017). Cellular and molecular effects of yeast probiotics on cancer. Critical reviews in microbiology, 43(1), 96-115.

Dasari, S, Kathera, C, Janardhan, A, Kumar, A. P, & Viswanath, B. (2017). Surfacing role of probiotics in cancer prophylaxis and therapy: A systematic review. Clinical Nutrition, 36(6), 1465-1472.

Sharifi, M, Moridnia, A, Mortazavi, D, Salehi, M, Bagheri, M, & Sheikhi, A. (2017). Kefir: a powerful probiotics with anticancer properties. Medical Oncology, 34(11), 183.

Sharifi, M, Moridnia, A, Mortazavi, D, Salehi, M, Bagheri, M, & Sheikhi, A. (2017). Kefir: a powerful probiotics with anticancer properties. Medical Oncology, 34(11), 183.

Nair, N, Kasai, T, & Seno, M. (2014). Bacteria: Prospective savior in battle against cancer. Anticancer research, 34(11), 6289-6296.

Dhama, K, K Latheef, S, K Munjal, A, Khandia, R, A Samad, H, MN Iqbal, H, & K Joshi, S. (2016). Probiotics in curing allergic and inflammatory conditions-Research Progress and futuristic vision. Recent patents on inflammation & allergy drug discovery, 10(2), 105-118.

Abd El Ghany, K, Hamouda, R, Abd Elhafez, E, Mahrous, H, Salem-Bekhit, M, & Hamza, H. A. (2015). A potential role of Lactobacillus acidophilus LA1 and its exopolysaccharides on cancer cells in male albino mice. Biotechnology & Biotechnological Equipment, 29(5), 977-983.

Rasouli, B. S, Ghadimi-Darsajini, A, Nekouian, R, & Iragian, G. R. (2017). In vitro activity of probiotic Lactobacillus reuteri against gastric cancer progression by downregulation of urokinase plasminogen activator/urokinase plasminogen activator receptor gene expression. Journal of cancer research and therapeutics, 13(2), 246.

Kumar, R, & Dhanda, S. (2017). Mechanistic insight of probiotics derived anticancer pharmaceuticals: a road forward for cancer therapeutics. Nutrition and cancer, 69(3), 375-380.